Everest Medicines

About:

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

Website: http://www.everestmedicines.com

Top Investors: Pavilion Capital, RA Capital Management, Hillhouse Investment, Janchor Partners, Rock Springs Capital

Description:

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in the Emerging Market and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in Asia Pacific territories and with leading global pharmaceutical companies.

Total Funding Amount:

$310M

Headquarters Location:

New York, New York, United States

Founded Date:

2017-01-01

Founders:

Number of Employees:

251-500

Last Funding Date:

2020-06-03

IPO Status:

Public

© 2025 bioDAO.ai